Market Place
Sourcing Support
Hillhurst Starts Ph2a Trial of HBI-002 for Sickle Cell Disease
23 Jul 2025 //
PR NEWSWIRE
Hillhurst Biopharma Completes Seed Financing To Advance Clinical Development
20 Dec 2023 //
PR NEWSWIRE
Hillhurst Biopharmaceuticals Receives $3 Million In Nih Sbir Funding
20 Sep 2023 //
PR NEWSWIRE
HILLHURST ANNOUNCES COMPLETION OF LAST PATIENT IN PHASE 1 TRIAL OF HBI-002
23 May 2023 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.